US EditionRNS Hotlist with Zak Mir: AZN, HEMO, POW, FDR, GMET, BZT, GGP, PR1, EPP, JET2, FTC & BARC
Summary by Share Talk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
RNS Hotlist with Zak Mir: AZN, HEMO, POW, FDR, GMET, BZT, GGP, PR1, EPP, JET2, FTC & BARC
The Times: FTSE 100 drugs giant AstraZeneca (AZN) has posted better-than-expected interim results boosted by strong sales of key cancer, heart and kidney disease drugs. Operating profit rose 23 per cent to $7.18Read More...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
